COMMUNIQUÉS West-GlobeNewswire

-
Nightstar Therapeutics to Present at Wedbush PacGrow Healthcare Conference
07/08/2018 -
Invitation: Terveystalo Half Year result audiocast and conference call on 17 August 2018
07/08/2018 -
BioCryst Reports Second Quarter 2018 Financial Results
07/08/2018 -
Fennec Pharmaceuticals Receives Positive Opinion on the Pediatric Investigation Plan From European Medicines Agency for PEDMARK(TM) and Confirmation of Eligibility for a Pediatric Use Marketing Authorization
07/08/2018 -
Shire plc : Director/PDMR Shareholding
07/08/2018 -
G1 Therapeutics to Present at Wedbush PacGrow Healthcare Conference on August 14, 2018
07/08/2018 -
EnvoyAI Partners with Mach7 Technologies to expand AI to Enterprise Imaging, VNA, and PACS
07/08/2018 -
Introducing New Weight Loss and Wellness Center: Healing at Sweetgrass
07/08/2018 -
Over 100 Physicians at the Florida Medical Association Conference Establish HealthLynked Profiles
07/08/2018 -
Transactions in relation to share buyback program
07/08/2018 -
Tecan schedules conference call on August 16th to discuss half year 2018 financial results
07/08/2018 -
Curetis Expands Geographic Presence with Entry into Northern African and Latin American Markets
07/08/2018 -
Curetis to Report its Half-Year Results 2018 on August 14, 2018
07/08/2018 -
Shire plc : Rule 2.9 Announcement
07/08/2018 -
Verona Pharma plc Operational Update and Financial Results for the Three and Six Months Ended June 30, 2018
07/08/2018 -
MDxHealth (R): MDxHealth Shareholder Transparency Declaration
07/08/2018 -
MDxHealth (R) : MDxHealth: Déclaration de Transparence d'un Actionnaire
07/08/2018 -
Syneos Health Announces Pricing of Secondary Offering of Common Stock
07/08/2018 -
MediciNova Announces Initiation of NIHR Grant-Funded Phase 2/3 Trial of MN-166 (ibudilast) for the Treatment of Degenerative Cervical Myelopathy in Collaboration with the University of Cambridge
07/08/2018
Pages